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Abstract
Heart valve anomalies are some of the most common congenital heart defects, yet neither the genetic nor the epigenetic
forces guiding heart valve development are well understood. When functioning normally, mature heart valves prevent
intracardiac retrograde blood flow; before valves develop, there is considerable regurgitation, resulting in reversing (or
oscillatory) flows between the atrium and ventricle. As reversing flows are particularly strong stimuli to endothelial cells in
culture, an attractive hypothesis is that heart valves form as a developmental response to retrograde blood flows through
the maturing heart. Here, we exploit the relationship between oscillatory flow and heart rate to manipulate the amount of
retrograde flow in the atrioventricular (AV) canal before and during valvulogenesis, and find that this leads to arrested valve
growth. Using this manipulation, we determined that klf2a is normally expressed in the valve precursors in response to
reversing flows, and is dramatically reduced by treatments that decrease such flows. Experimentally knocking down the
expression of this shear-responsive gene with morpholine antisense oligonucleotides (MOs) results in dysfunctional valves.
Thus, klf2a expression appears to be necessary for normal valve formation. This, together with its dependence on
intracardiac hemodynamic forces, makes klf2a expression an early and reliable indicator of proper valve development.
Together, these results demonstrate a critical role for reversing flows during valvulogenesis and show how relatively subtle
perturbations of normal hemodynamic patterns can lead to both major alterations in gene expression and severe valve
dysgenesis.
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Introduction
Formation of valves is a critical step in the development of a
functionally mature heart, yet little is known about the
mechanisms that initiate valve formation in vivo. In vertebrates,
valves form from the endothelial cell layer located at the border
between the atrium and the ventricle [1–3]. In fish, this region is
called atrioventricular (AV) canal [1,4,5] and defines the
endothelial ring [6]. The expression of genes specific to this
territory depends on the activity of molecules secreted in the
subjacent AV myocardium and on an elaborate combination of
signaling pathways between the two cell layers, including Wnt/b-
catenin, bone morphogenetic protein (BMP), and Notch signaling
[4,7–10]. Not surprisingly, aberrant patterning of the myocardial
layer of the early heart can lead to valve defects, as the
specification of the AV canal is impaired [6]. The analysis of
zebrafish mutants has led to the identification of several cellular
changes happening in the endothelial cell precursors during the
process of valvulogenesis [1], and it has been shown that some of
these changes are associated with physical stimuli provided by
blood flow [11]. Interestingly, valve morphogenesis is clearly
dependant on the geometry of the beating heart chambers, further
suggesting that the physical environment near the developing
valves plays a critical role for their development [11]. Along with
previous observations demonstrating the importance of intracar-
diac fluid flow for cardiogenesis [4,12–14], this offers the exciting
possibility that the genetic programs that govern valve formation
in vivo depend on intracardiac hemodynamics. Harvesting this
possibility has been challenging, as some attempts to uncouple
contractility and flow have been taken to suggest that they play
opposing roles in modulating cell shape within the developing
heart [12]; other studies have suggested that flow forces regulate
looping, cell size and shape in the heart chambers, and the
formation of trabeculae [5,12–14]. A recent publication highlights
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the uncertainty concerning the role of flow during heart valve
development, since it reports a cardiac contractility mutant that
can form normal valves [15]; thus, something more than the mere
presence (or absence) of flow or contractility must be involved in
directing valve development.
The predominant model to explain endothelial cell response to
flow envisions that the shear stress, which directly depends on the
viscosity and the velocity of the blood, is the main physical
stimulus. More recently, disturbed flow has been used as a general
term to group abnormal flow patterns (including low flow,
oscillatory flow, flow separation, gradients, turbulence, and
reversing flows), potentially leading to atherogenic stimulus for
endothelial cells [16–18]. This hypothesis is indirectly supported
by observation that, in vitro, endothelial cells can be responsive to
disturbed flows [19,20], leading to an atherogenic-like cell
response [21]. Thus, an attractive hypothesis is that heart valves
form as a developmental response to disturbed blood flows. A key
prediction from this model is that altering flow patterns within the
heartbeat cycle should directly affect valvulogenesis. In vitro
approaches have so far been unsuccessful in addressing this
question, possibly due to the absence of specific valve markers
usable in vitro and to the difficulty to mimic in vitro the
complexity of flow patterns observed in vivo.
To circumvent these limitations, we characterized embryonic
zebrafish heart flow in vivo to identify a critical feature of the flow
pattern associated with valve specification and tested its impor-
tance using a set of experimental manipulations including both
genetic and pharmacological approaches. Taking advantage of
high-speed imaging, we quantified the flow patterns generated in
the beating heart and compared them with anatomical landmarks
of the heart specified by expression patterns of known genes. Using
antisense morpholine oligonucleotides (MOs) and drugs to alter
these flow patterns in zebrafish, we show that reversing flow is
essential to trigger flow-responsive genes in the AV canal and for
initiating valvulogenesis. Our findings validate a key prediction of
a specific and local role for reversing flows during cardiogenesis.
Results
Reversing Flows Are Higher in the AV Canal
In order to better understand the roles played by blood flow in
heart and valve development, we have developed imaging
techniques to capture cardiac motion and analyze blood flow.
Imaging with these tools reveals dramatic changes in intracardiac
blood flow patterns during cardiac development: as the heart
enlarges, blood flow becomes increasingly bidirectional until the
stage at which functional valve leaflets emerge at the boundary
between the atrium and the ventricle (Figure S1, Video S1, and
unpublished data, see also [11,22]). Although reversing blood
flows are at times visible in the atrium and ventricle, reversing
flows are most pronounced at the AV canal in the second and
third days of development (Figure 1A–1C, Video S2). We
quantified the degree of reversing flow by measuring the fraction
of the cardiac cycle during which there is retrograde flow, and
term this the retrograde flow fraction (RFF). RFF is largest at the
AV canal at embryonic stages that precede valve formation. Our
ability to observe intracardiac blood flow simultaneously with
heart pumping dynamics and morphogenetic changes provides a
direct means to assess the proposal that the presence of particular
patterns of intracardiac blood flow play a critical role in heart
valve development.
To better understand how reversing flow relates to valve
development at the molecular level, we analyzed the expression
pattern by in situ hybridization (ISH) of three known shear-related
genes at the AV canal: notch1b, a zebrafish Notch homolog
[23–25], klf2a, a transcription factor from the Kruppel-like factor
(Klf) family [26], and bmp4, a secreted growth factor of the bone
morphogenetic protein (Bmp) family [27]. Notch is essential for
valve formation [28], and the Notch pathway is activated by shear
stress in HUVEC cells [29–31]. klf2a and bmp4 are expressed in the
zebrafish conduction system [4,21,25]. Our analysis concentrated
on the AV canal during its specification (between 22 and 48 hours
postfertilization [hpf]) [4,25] as well as slightly before valve leaflet
formation (58 hpf) [11] (Figure 1G–1O). Both notch1b and klf2a
were expressed in the endothelium (Figure 1G–1L; Figure S2,
Video S3). In contrast, bmp4 was expressed in the myocardium of
the heart tube, starting around 20–22 hpf and later became
restricted to the AV canal between 36 and 58 hpf (Figure 1M–
1O). Strikingly, expression of notch1b, klf2a, and bmp4 became
restricted to the region of high reversing flow we identified in the
AV canal as the heart matured.
Reversing Flows Control Valve Morphogenesis in
Addition to Shear Stress
In the developing zebrafish heart, where the Reynolds numbers
are much less than one [14], flow patterns are dominated by the
relationship between viscous forces and pressure gradients [32].
Thus, two methods of altering the reversing intracardiac blood
flows in vivo are to: (1) manipulate blood viscosity, or (2) modulate
pacemaker activity in order to change intracardiac pressure
gradients [33]. To alter blood viscosity, we lowered the hematocrit
by targeting two genes controlling early hematopoiesis in
zebrafish, gata1 and gata2 [34], with MOs. Embryos injected with
gata1 MO are completely devoid of circulating blood cells [34],
have a lower blood viscosity (reduced by ,90%, see Materials and
Methods), and display an increased RFF compared to controls
(Video S4; ,RFF: 45%612% in gata1 morphants, compared to
35%67% in controls, Figure 2A and 2B). Embryos injected with
gata2 MO contain fewer circulating blood cells in comparison to
wild-type embryos (72% fewer blood cells, Figure 2L, Video S5),
have a reduced viscosity (,70% lower than controls), and display
Author Summary
The growth and development of vertebrates are critically
dependent on efficient cardiac output to drive blood
circulation. An essential step of heart development is the
formation of heart valves, whose leaflets are made through
a complex set of cellular rearrangements of endothelial
cells. Endothelial cells experience high flow forces as blood
circulates. Moreover, heart valves and associated structures
can be malformed when flow forces are abnormal,
suggesting that these flow forces are in fact required for
proper valve formation. Whether it is the force of the
blood flow, its directionality (forward or reverse), or both
that are important is not clear. We studied the interplay
during valve development between key genes known to
be involved in the process and epigenetic influences such
as flow forces. Using zebrafish, whose optical clarity allows
analyzing blood flow patterns at high resolution, we
identified the presence of reversing flows specifically at the
level of valve precursors. By manipulating blood flow
patterns, we show that reversing flows are essential for
valve morphogenesis. Specifically, we show that the
expression of the gene klf2a depends on the presence of
reversing flows and is required for valve development. We
predict that by influencing levels of klf2a, reversing flows
constitute an important stimulus controlling the appropri-
ate biological responses of endothelial cells during valve
formation.
Reversing Blood Flows during Valvulogenesis
PLoS Biology | www.plosbiology.org 2 November 2009 | Volume 7 | Issue 11 | e1000246
Figure 1. Transvalvular oscillatory flow patterns change during heart valve morphogenesis and gene expression in the AV canal.
(A–C) Average transvalvular flow direction as a function of time for wild-type hearts as seen in the AV canal (light magenta box) or atrium (light blue
box) between 36, 48, and 58 hpf in the area highlighted in the heart drawings (ventral view, anterior to the top). Anterograde flow from the atrium to
ventricle is shown in black, retrograde flow from the ventricle to the atrium in red, and no flow between the chambers is shown in white. The
sequence of time segments with retrograde, anterograde, and no-flow fractional periods are depicted in red, black, and white, respectively. The
retrograde flow fraction (RFF) is the fraction of the cardiac cycle that is red. (D–F) cmlc2 expression reveals changes in heart morphology. cmlc2 is
expressed in the heart tube in the anterior region at 36 hpf (D), and is expressed strongly in the ventricle and weakly in the atrium at 48 and 54 hpf (E
and F). (G–O) Expression of notch1b, klf2a, and bmp4 progressively becomes localized to the AV canal during valve specification. mRNA distribution of
notch1b (G–I), klf2a (J–L), bmp4 (M–O) at 36 hpf (D, G, J, and M), 48 hpf (E, H, K, and N), and 56 hpf (F, I, L, and O). notch1b is found in the anterior part
of the heart tube at 36 hpf (G), and becomes stronger in the AV canal and in the ventricle at 48 hpf (H). At 54 hpf, notch1b expression becomes
restricted in the AV canal and the outflow tract (I). klf2a expression is found throughout the heart tube at 36 hpf (J) and becomes stronger in the AV
canal and in the atrium at 48 hpf (K). At 56 hpf, klf2a is exclusively expressed in the AV canal and the outflow tract, displaying an expression pattern
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a strongly reduced RFF (17%64% of the heart cycle, Figure 2C;
Video S4) in a majority of embryos (n=13, 54%), highlighting the
nonlinear relationship between heartbeat frequency and viscosity.
When analyzed at 96 hpf, a majority of gata1 embryos had normal
valves (77% of embryos had normal valves, n=13; Figure 2F and
2L); in contrast, the majority of gata2 morphants displayed severe
valve defects (64% of the embryos displayed abnormal valves,
n=14; Figure 2G and 2L). To make sure that the abnormal valve
development was related to the lower RFF and not to other
functions of gata2, we analyzed the effect of simultaneously
inactivating gata1 and gata2. This treatment further reduced blood
viscosity, restored the RFF to 50% (Figure 2D, Video S4), and
rescued valve formation (87% of embryos had normal valves,
n=8; Figure 2H and 2L). We also confirmed that lack of blood
cells does not affect heart chamber patterning and vascular
development (Figure S3). Because shear force depends directly
upon viscosity, the reduced blood viscosity resulting from the gata1
or gata1/2 MOs reduces the magnitude of the shear forces
throughout the cardiovascular system with respect to normal or
gata2 morphants (Figure S4). Thus, the normal valve development
of the gata1 and gata1/2 morphants, and the abnormal valve
development in the gata2 morphants show that reversing flows,
rather than magnitude of shear stress alone, are critical for valve
leaflet formation (Figure 2M).
To better define the effects of RFF alteration in the gata2
morphants, we used quantitative reverse transcriptase PCR (qRT-
PCR) to study a set of flow-responsive genes. We compared
expression of bmp4, klf2a, notch1b, neuregulin1 (nrg1), and endothelin1
(edn1) in wild-type, gata1, and gata1/2 morphant embryos
(Figure 2I–2K). Their expression levels in the gata1 morphants
remained close to the control baseline (Figure 2I), as did their
levels in gata1/2 morphants, except for a slight decrease in bmp4
expression (about 2-fold, Figure 2K). In gata2 morphants, two
genes were significantly down-regulated: klf2a (about 5-fold
reduction) and notch1b (about 2.5-fold reduction); edn1 and nrg1
display a mild reduction (about 1.5-fold reduction, Figure 2J).
Since wall shear stress (WSS) is a major stimulus for endothelial
cell response in vitro, we explored whether it is also associated with
the developmental changes we observe in vivo. Blood cell velocity
measurements were used to estimate the WSS generated in the AV
canal in control and altered flow conditions (summarized in Figure
S4). In all gata morphants, the WSS is decreased due to the
reduced blood viscosity. Interestingly, although gata2 and gata1
morphants display comparable amounts of WSS, they have
opposite valve phenotypes. Thus, WSS magnitude cannot be the
only determining factor for valvulogenesis. To explore this
relationship further, we analyzed four heart contractility mutants
(cx36.7, myh6, ttna, and sih; Figure S5A–S5E), and find that they
have widely varying RFFs (Video S6). Furthermore, the mutants
exhibiting a decreased RFF demonstrate both reduced klf2a
expression (Figure S5F–S5H) and increased valve dysgenesis
(Figure S5C, S5D, S5I, and S5J). Thus, results from animals with
reduced blood viscosity and with reduced heart contractility
suggest that, for normal development of valves, the reversing
nature of the WSS is more important than its magnitude.
klf2a Is Modulated by Low RFF in the AV Canal
We further explored the relationship between RFF and valve
development by using lidocaine, a sodium channel blocker, to
decrease heart rate [35], as well as increased temperature to
increase heart rate [33]. Lidocaine increases the time from
ventricular contraction to the atrial contraction of the next
heartbeat, thus lengthening the period between the onset of the E
wave (early diastolic filling due to ventricular suction) and A wave
(ventricular filling due to atrial contraction). Slowing the heart rate
by only 30% reduced the RFF by as much as 60% (Figure 3A).
Similarly, warming the animal by 2–4uC sped up the heart and
reduced the RFF (Video S7). Because lidocaine is easily applied
and rinsed out, we could decrease the RFF for defined periods to
find the stages at which oscillatory flow is critical for valve
development. Starting at 24, 36, or 48 h of development, we
incubated fish in lidocaine for either 12 or 24 h, after which the
fish were returned to normal medium (Figure 3B). When scored at
96 hpf, valve leaflets were evident in all control embryos (no
lidocaine exposure; Figure 3C; Video S8). In contrast, fish in
which lidocaine reduced the RFF displayed a range of valve
defects (Figure 3B, blue bars and red bars). Similar defects were
observed after reducing the RFF with elevated temperature
(Figure 3B, yellow bars). In the subtlest defect manifestations,
valve leaflets did not form (Figure 3D; Figure S3B; Video S8). In
more extreme cases, the heart retained an immature tubular shape
(17%, n=36; Figure S6). The defects cannot be from a side effect
of the lidocaine, as slight warming of the animals to restore heart
rate, and thereby RFF, to normal rescued valve leaflet formation
(Figure 3E, 3H, and 3K, Video S8). The highest proportion of
valve defects resulted when 12- or 24-h lidocaine treatments were
initiated at 36 hpf, suggesting the greatest sensitivity to decreased
RFF from 36–48 hpf (Figure 3B). Interestingly, this time window
corresponds to the period when bmp4, notch1b, and klf2a normally
become restricted to the AV canal.
To explore the timing relationships between the flow-responsive
genes, we analyzed their expression by ISH after a 5- or 15-h
lidocaine treatment, starting at 31 hpf. klf2a expression signifi-
cantly decreased in as little as 5 h of treatment (Figure 3, compare
3F and 3G), indicating that klf2a may be an immediate target of
the mechanism(s) that sense RFF. In contrast, expression of notch1b
was normal after the short lidocaine treatment, but was decreased
after 15 h of treatment (Figure S7). Quantitative PCR studies
show that klf2a, edn1, and notch1b were strongly down-regulated
after 10 h of lidocaine treatment, started at 36 h, (about 5-fold
reduction compared to controls); whereas nrg1 and bmp4
expression levels were almost normal (Figure 3L and 3M). Shorter
treatments (6 h) led to a significant decrease in klf2a and nrg1
mRNA levels (about 2.5- and 2-fold reduction, respectively),
suggesting that these two genes may be primary targets of
retrograde flow (Figure 3L). The strong dependence of klf2a
expression on the presence of oscillatory flow during both the 6- or
10-h treatments, as well as the similarity of its expression kinetics
to those observed in cell culture [36], makes klf2a an excellent
candidate as a key component in mediating the effects of
oscillatory flow on valve specification, validating the proposed
involvement of this gene in vertebrate cardiogenesis [37–39].
klf2a Knock Down Affects Valvulogenesis
We tested whether klf2a is required for valve formation by
knocking down its expression using MOs, and obtained AV valve
dysgenesis phenotypes that were remarkably similar to those of
embryos exposed to reduced oscillatory shear stress (scored at
very similar to notch1b (L). bmp4 expression is found in the anterior part of the heart tube at 36 hpf (M) and becomes progressively concentrated at
the level of the AV canal from 48 to 54 hpf (N and O). Anterior to the top, white arrows point to the AV canal, black arrows to the outflow tract. Scale
bar indicates 50 mm.
doi:10.1371/journal.pbio.1000246.g001
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Figure 2. Decreased retrograde flow via lowered blood viscosity affects valve morphogenesis. (A–D) Flow pattern at 48 hpf in (A)
control and after (B) gata1, (C) gata2, and (D) gata1/2 knock down. gata2 inactivation leads to a dramatic decrease in the RFF, whereas gata1 and
gata1/2 knock downs exhibit increased RFF compared to the control. (E–H) Confocal sections of the valve-forming region in (E) control, (F) gata1, (G)
gata2, and (H) gata1/2 morphants. Only gata2 morphants at 96 hpf show valve dysgenesis. Scale bar indicates 50 mm. (I–K) Quantitative RT-PCR
showing the expression level of several flow-responsive genes after gata1, gata2, or gata1/2 knock down. **p,0.01, ANOVA. (L) Percentage of
embryos displaying valve malformation at 96 hpf (red bar), hematocrit level (yellow bar), and RFF (blue bar) observed in morphants and controls at
48 hpf. The proportions were significantly different at a 10% level of significance (a= 0.1). (M) Outline summarizing the experimental outcome of
manipulating oscillatory flow by decreasing circulating blood cells. The color code for gene expression is the same as in (I).
doi:10.1371/journal.pbio.1000246.g002
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96 hpf; Figure 4A–4D); 52% of klf2a MO-treated embryos (n=36)
revealed valve dysgenesis; none of the sham- or control-injected
embryos (n=45) showed abnormal valve development (Figure 4A–
4D). This similarity in phenotypes suggests that expression of klf2a
is a key part of the genetic program that makes valve development
responsive to normal oscillatory flow (Figure S8). In mouse, loss of
Klf2 is associated with heart failure and altered cardiac output
[38]. In our studies, the zebrafish klf2a morphants displayed a
heart rate similar to that of the control embryos at 48 hpf (1.7 Hz;
Figure 4E and 4F), and had normal flow patterns within the AV
canal (n=5, Figure 4E and 4F). We found that atrial and
ventricular fates are properly assigned in the klf2a morphants,
because the chamber-specific expression of nppa, bmp4, and cmlc2
appear normal (Figure 4G and 4H; Figure S9A–S9D). Thus, the
effects of our MO experiments are not secondary to an alteration
in heart structure or blood flow. ISH revealed that the first
apparent molecular defects in the klf2a morphants are a decrease
in notch1b expression at 36 hpf and a lack of notch1b expression at
the AV boundary of the heart at 46 hpf (Figure 4L and Figure S9E
and S9F), consistent with previous work showing that klf2 lies
upstream of Notch in HUVEC cells [40]. In contrast, bmp4
expression is normal at 36 hpf and slightly decreased at 46 hpf
(Figure 4I and 4J and Figure S9C and S9D). When measured by
qRT-PCR, the expression levels of bmp4, edn1, and nrg1 were lower
than normal by at least a factor of two (Figure 4M); the strong
decrease in notch1b expression seen by ISH corresponds to a 10-
fold reduction compared to controls (Figure 4M). Together with
the fact that klf2a expression is a primary target of oscillatory flow,
these data indicate that klf2a functions upstream of many known
flow-induced genes in the process of AV valve formation in
response to oscillatory flow.
Cell Shape Is Affected by Decreased Reversing Flows
during Valve Invagination
Zebrafish valves emerge from the endothelium through the
combined actions of cell rearrangements and cell shape changes
[1,11]. To characterize the leaflet phenotype in the different
mutants exhibiting altered RFF, we analyzed cell number and cell
Figure 3. Decreased oscillatory flow decreases klf2a expression. (A) RFF is decreased by alterations in heart rate. The highest RFF is seen at
the control heart rate (.30% between 1.5 and 2 Hz) at 48 hpf. Raising fish at lowered or elevated temperatures slows or speeds heart rate and
significantly decreases RFF. Lidocaine treatment decreases heart rate and RFF (blue data point). The decreased heart rate and RFF is rescued by
elevating the temperature to 34uC (red data point). (B) Decreased RFF from treatment with lidocaine or with high-temperature (34uC) leads to valve
defects. The maximal effect is observed when treatment is initiated at 36 h. (C–E) Valve formation in normal and lidocaine treated embryos. (C)
Embryos that were raised in control conditions have valve leaflets (white arrows). (D) Embryos in which RFF was decreased by lidocaine treatment
from 31 to 55 hpf have endocardial tissue thickening (asterisk) but no valve leaflets are apparent (50%, n=36). (E) Heart valve dysgenesis in fish
exposed to 0.15% lidocaine for 24 h is rescued by incubating it at 34uC to restore normal RFF. Heart valve leaflets are present and function normally
(white arrows). All embryos are imaged at 96 hpf. A, atrium; V, ventricle. (F–H) klf2a expression in 46-hpf-old embryos is altered by lidocaine
treatment. (F) klf2a expression is localized at the AV boundary in control embryos. (G) klf2a expression decreases after 15-h lidocaine treatment (90%,
n= 67). (H) Restoring heart rate and RFF to normal by raising the fish at 34uC restores klf2a expression (90%, n= 45). Anterior to the top. (I–K) nppa
expression remains largely unaffected by lidocaine treatment and temperature rescue. (L) Quantitative RT-PCR showing the expression level of
several flow-responsive genes after lidocaine treatment. klf2a expression is significantly decreased after 6 and 10 h of treatment and is restored by
incubation at 34uC; 100% of expression corresponds to a normal expression level. *p,0.05; **p,0.01, ANOVA. (M) Outline summarizing the
experimental outcome of decreasing oscillatory flow by decreasing heart rate. The color code for gene expression is the same as in (L).
doi:10.1371/journal.pbio.1000246.g003
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Figure 4. Morpholine antisense oligonucleotide treatment decreases expression of the flow-responsive gene klf2a results in valve
dysgenesis. (A–D) Valve leaflets scored at 96 hpf show effects of klf2a MO. (A and C) Sham-injected embryos form normal heart valves. (B and D)
klf2a MO-treated embryos display valve dysgenesis, often with a complete absence of valve leaflets. (C and D) Detailed views of valve morphology.
(C) Control embryo has clearly distinguishable valve leaflets (arrows). (D) klf2a MO-treated embryo has no valve leaflets forming from the
endocardium (arrow) (52%, n=46). The proportions were significantly different at a level of significance a= 0.01. Scale bars indicate 50 mm. (E and F)
Average flow pattern at 48 hpf in controls (E) and klf2a morphants (F) showing that the RFF is unaffected in the mutants but that the heart rate is
slightly decreased. (G–L) Expression of three marker genes at 48 hpf in normal and klf2a morphants. (G–J) nppa expression is normal in the klf2a
morphants, showing that chamber specification occurs independently of klf2a. (I and J) bmp4 mRNA distribution at 48 hpf showing that expression is
decreased in the MO-treated embryo in the AV node region at 48 hpf (n=23, 40%; compare expression at arrow in panels [I and J]). (K and L) notch1b
expression at 48 hpf decreases in the AV boundary of the klf2a morphants (n= 45, 71%). Arrows point to the AV boundary in all panels (G–L). (M)
Summary of quantitative RT-PCR showing the expression level of flow-responsive genes in klf2a morphants. Expression of all genes decreases
significantly, confirming the down-regulation of bmp4 and notch1b observed by ISH. **p,0.01, ANOVA. (N) Summary diagram of klf2a function
Reversing Blood Flows during Valvulogenesis
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shape using the Tg(flk1:gfp) fish line [41] at 72 hpf, a stage at which
the valve invagination is clearly visible [11]. In this line, the GFP
accumulates in endothelial cells, but the fluorescence level is
different from cell to cell. The inherent brightness variation allows
us to count and assess the shape of every endothelial cell in the
heart. Focusing our analysis on the AV canal, we found that the
endothelial ring forms in every morphant and lidocaine-treated
embryo (Figure 5A–5E). Strikingly, gata1 and gata1/2 morphants
display normal cell numbers in the AV canal (Figure 5A and 5B
and unpublished data); however, all treatments that disrupt the
invagination of valve leaflets (gata2 MO, klf2a MO, and lidocaine)
exhibit decreased endothelial cell number in the AV canal
compared to the controls. Three-dimensional volumetric mea-
surement of the endothelial AV cells reveals that wild-type controls
as well as the gata1 and gata1/2 morphants possess endothelial cells
that are cuboidal (Figure 5A and 5B, 5F–5G, and 5Q; Video S9);
in contrast, the endothelial cells remain flat and elongated in gata2
morphants, klf2a morphants, and lidocaine-treated embryos
(Figure 5C–5E, 5H–5J, and 5Q; Video S9). These differences
precede the absence of valve invagination in embryos with
decreased RFF and suggest that cell remodeling is important for
leaflet morphogenesis. Taken together, our results show that the
loss of klf2a expression, lack of invagination, decreased endothelial
cell number, and abnormal endothelial cell shape characterize the
effects of decreased RFF.
Discussion
The beating heart is a highly dynamic structure. Its contraction
generates multiple types of forces at different scales: Although both
the myocardial and endocardial cells undergo a compression-
stretching sequence during each contraction at the tissue scale,
individual endothelial cells directly experience shear stress and
oscillatory flows generated by moving blood. Although it is well
established that both cell types are responsive to mechanical cues
[17,42–44], it has been difficult to clearly state which is the
mechanical stimulus activating endothelial cells to respond to flow.
To address this question, we have applied fast imaging on live
embryos to carefully describe the flow patterns generated at the
earliest stages of the valve development. Based on analysis of both
live embryos and gene expression in fixed tissues, we find that the
specific accumulation of klf2a transcripts within the valve precursor
correlates with the presence of reversing flow in the AV canal and
that altering flow patterns in the AV canal affects gene expression
patterns in the endothelial cell layer. The differential response of
endothelial cells to the presence or absence of reversing flows gives
rise to an area prone for valvulogenesis. This response gets
reinforced as reversing flows gradually concentrate in the AV
canal. This phenomenon can be explained by the progressive
reduction of the AV diameter as the atrium and ventricle loop, and
the endothelial ring develops. Our results show that valvulogenesis
results through the combination of a complex set of morphoge-
netic changes and are in full agreement with the different studies
on the subject [5,6,11–14,45].
The Morphogenesis of Valve Leaflets Depends on Blood
Flows in Zebrafish
In zebrafish, the first step of valvulogenesis involves the
clustering of endothelial cells at the AV boundary. Cells coalesce
to form an endothelial ring lining the AV canal between 24 and
48 hpf [6]. As seen previously [6], we found that flow is not
necessary for endocardial ring formation. However, blood flow is
critical for cell shape change and leaflet invagination. Knocking
down klf2a does not affects endothelial ring formation, confirming
that klf2a function starts when its expression becomes detectable in
the AV canal. Our data together with those of others [11] show
that the endothelial ring is assembled in a region coinciding with
klf2a expression, and that reversing flows progressively increase in
amplitude specifically at the AV canal after the endothelial ring
forms. This timing suggests that the effects of blood flow act after
an initial patterning that is guided by a genetic program,
reminiscent of the process acting in vascular development [46].
Thus, it appears that the earliest steps of heart development can be
considered as genetically hardwired, but that secondary events,
such as valvulogenesis, are contingent on the presence of reversing
flows.
Zebrafish valve development appears to be somewhat divergent
from the process described in amniote vertebrates. In chicken and
mice, valve leaflets arise from a mesenchymal cushion; in
zebrafish, valves emerge directly through an invagination of the
AV endothelium [11]. The origins of this morphogenetic process
are unclear, but it allows the maturation of a functional valve in
less than 96 h of embryonic development [11,22]. Our results
show that this morphogenetic mechanism is dependent on
reversing flow forces. Interestingly, the absence of invagination
correlates with a lack of cell shape change that would normally
occur during this process. Many observations using endothelial cell
culture have shown that the presence of flow activates signaling
pathways implicated in cytoskeletal remodeling [17,31]. It is thus
tempting to speculate that reversing flows initiate the invagination
process by stimulating the necessary movements and cytoskeletal
rearrangements of endothelial cells in the AV canal to build a
functional valve.
Necessity and Modulation of klf2a Expression for Normal
Valve Formation Highlights the Genetic Link between
Biomechanical Stimulus and Cell Response to Reversing
flows
The formation of heart valves allows unidirectional flow to be
sustained as the peripheral vasculature develops and the increase
in systemic resistance reduces the net flow of the valveless heart
that results in the appearance of retrograde flow. The RFF is
greater in the AV canal than in the rest of the heart or the
cardiovascular system. The AV canal, a constriction, is exposed to
high hemodynamic forces due to the higher velocities generated in
areas with reduced cross section. Our studies clearly show that,
although the drop in WSS magnitude affects gene expression levels
in the heart, they are not sufficient to explain the abnormality in
valve formation. Another aspect of the WSS, namely its oscillating
directionality due to reversing flows, has to be included to
understand the apparition of valve abnormalities in the gata2
morphants and not in the gata1 morphants where the shear forces
are the lowest. Our quantitative imaging analysis strongly suggests
that reversing flows are the proper stimulus controlling valve
formation. Reversing flows have been observed in the developing
cardiovascular system of many vertebrates ([47] and S. E. Fraser,
unpublished data) and could be involved in other important steps
during heart valve formation. klf2a acts as a transcriptional relay between the reversing flow generated by the circulating blood cells at the AV canal
and several genes activated in the AV endothelial cells (such as notch1b, neuregulin1, and endothelin1). klf2a also affects the expression of bmp4,
revealing a possible interaction between myocardium and endothelium essential for valve morphogenesis.
doi:10.1371/journal.pbio.1000246.g004
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Figure 5. Comparison of the valve phenotype between the different treatments affecting valvulogenesis in transgenic Tg(flk1:EGFP)
zebrafish at 72 hpf. GFP is expressed in the endothelial cell layer and highlights the developing valves. (A, F, and F’) control embryo, (B, G, and G’)
gata1 morphant, (C, H, and H’) lidocaine treated, (D, I, and I’) gata2 morphant, and (E, J, and J’) klf2a morphant. Each treatment lead to an incomplete
ingression of the endothelial cells in order to make a functional leaflet except in gata1 morphants. (F’–J’) Schematic representation of the panels (F–J)
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of cardiovascular development. Among the many genes responsive
to flow, klf2a seems to be specifically responsive to disturbed flows
as observed both in vivo (this study) and in vitro [36]. Although, a
direct involvement of klf2 (the homolog of klf2a in mouse) during
valve development remains to be uncovered in higher vertebrates,
this study should stimulate investigation of subtler valve alterations
in these mutants [38]. Genetic evidence also suggests that klf2 has
atheroprotective roles in adult mice [48] and humans [21], further
suggesting that klf2, reversing flows, and cardiac physiology and
development are tightly interconnected and that klf2 could also be
implicated in the flow response during these processes. klf2a stands
out as a possible early indicator of defective valve development.
Nevertheless, it is clear that a number of other genes are mediating
the response of endothelial cells to flow and that more
investigations will be required to isolate them all as well as
determine their interconnections.
Reversing Flows Constitute a Unique Physical Stimulus
for Valve Development
Given that heart-pumping activity and blood content constantly
change as the heart develops, a patterning mechanism based on
flow sensing provides a very practical way to coordinate the timing
of valve formation with the pumping efficiency of the heart. In the
context of valvulogenesis, reversing flows constitute an efficient
signal by providing specific stimuli that dynamically locate the
valve forming area. This hypothesis is fully consistent with
emerging models arising from studies addressing the role of
biomechanical stimuli during embryogenesis, which suggest that
extrinsic forces and intrinsic hardwired programs are intercon-
nected into feedback loops [49,50]. The advantage of such a
mechanogenetic interplay is that it offers the opportunity for cells
to locally adjust to the rapid environmental changes occurring in
dynamic environments in conjunction with organizing centers
[51]. In such systems, cells can directly react to the dynamics of the
organ and can properly adapt at the single-cell level to organize as
a coherently growing tissue. In conclusion, we have demonstrated
that heart rate and blood viscosity can modulate the duration of
oscillatory flow in vivo and have presented a set of useful methods
to control hemodynamic forces during cardiogenesis. Together,
these simple approaches offer powerful tools for predicting and
potentially treating dysgenesis of cardiac valves and broaden the




The Zeiss LSM 510 was used to image Tg(flk1:gfp) and
BODIPY-ceramide (Molecular Probes) stained embryos to
visualize valve structure. Embryos were anesthetized prior to
imaging in 0.0175% tricaine and placed in agarose wells. All
images were taken with a 406/1.1 LD C-Apochromat water
immersion lens. For high-speed imaging, the Zeiss LSM 5 LIVE
was used to image BODIPY-ceramide–stained embryos and to
visualize valve formation and flow patterns. Images of 2566256
pixels were acquired at 151 frames per second.
High-Speed Video Microscopy
Brightfield images were taken with a Basler A602f CMOS
camera mounted on a home-built microscope equipped with an
Olympus 0.5 NA 106 air objective coupled with a 300-mm focal
length tube lens. Images were acquired at 216 frames per second.
Transvalvular Flow Characterization
Transvalvular blood flow was characterized as positive,
negative, or absent (no flow) by analyzing blood cell motions
across the developing valve leaflets. For embryos lacking blood
cells, the plasma was labeled by injecting microbeads (Bangs
Laboratories) into the yolk sac. The region of interest was defined
relative to the atrium and ventricle and moved with the valve
plane during the cardiac cycle. Blood flow direction was marked in
every frame taken during the cardiac cycle, and the retrograde
flow fraction (RFF) was determined by dividing the total number
of frames exhibiting retrograde flow by the total number of frames
per cycle. For each treatment, five to 15 embryos were analyzed.
The boxes represented in Figures 1, 2, and 4 represent the average
flow observed during a minimum of ten heartbeats.
Shear Stress Estimates
Instantaneous blood cell velocity as a function of heart cycle
time in the developing heart was assessed at 48 hpf by tracking
blood cells manually in the AV canal over an average of four
frames. Two heartbeats were analyzed in each condition. Shear





where U is the centerline velocity, a is the half-width of the region
of interest (that is, the radius), and y is the distance from the wall.








where m is the dynamic viscosity of the fluid with units g?cm21?s21.
We measured the AV canal diameter every ten frames to set a (on
average a=5 mm).





We assumed that the size of a cell in the AV canal was constant
using 10 mm2 as its exposed surface area. The energy expenditure
during one cardiac cycle (E, in dyne?cm) on a single cell is
therefore given by
E~F|U|RFF|f{1,
underlining the endothelial cells within valve-forming region (yellow) and the heart lumen (white). A, atrium; V, ventricle. (K–O) Three-dimensional
reconstruction of 10 mm depth of the AV area in control (K), gata1 morphants (L), lidocaine-treated embryo (M), and gata2 (N) and klf2a (O)
morphants. The white arrows point to the cell that has been reconstructed in three dimensions and which is presented in (P–T). (P–T) Side view (left)
and top view (right) of a reconstructed cell of the AV canal. (U) Schematic drawing showing the approach used to define cuboidal versus non-
cuboidal cell shape. (V) Graph summarizing the number of cells counted in the AV canal (corresponding to the yellow cells in [F’–J’]) (blue bars), and
the ratio between cuboidal versus non cuboidal cell shape (red bars). Yellow arrows in (A–E) point to the endocardial ring.
doi:10.1371/journal.pbio.1000246.g005
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where RFF is the retrograde flow fraction and f is the heart
rate (s21).
Hematocrit Count
Blood cells were imaged within the eye capillary. We counted
the number of cells crossing a virtual line during the same time
window in controls and MO-treated embryos (Video S5). Blood
viscosity in gata morphants was estimated using the plot of relative
viscosity versus particle volume fraction [52] after measurement of
the particle volume fraction assuming fish blood composition is
similar to that of humans.
Lidocaine Treatment
Heart rates of experimental embryos were decreased by dosage-
dependent exposure to lidocaine added to the bathing solution.
Lidocaine was drawn from the stock solution (1% stock, Abbott
Laboratories) and diluted into wells containing artificial pond
water and approximately five embryos. Embryos were exposed to
lidocaine for 24 h beginning at 31 hpf, the developmental stage
marked by the transition from unidirectional to bidirectional flow.
Assays of valve morphology and function were carried out at
96 hpf, a stage in which all wild-type fish hearts have at least one
well-developed valve leaflet. Surviving embryos (.80%) were
washed three times, placed in artificial pond water, and incubated
at 28.5uC until being imaged (4 dpf). Normalized heart rates were
calculated by dividing the heart rates of individuals (n=30)
exposed to lidocaine by the heart rates of individuals under control
conditions. Heart rates were measured after 1 h of continuous
exposure to lidocaine (Figure 2A).
Temperature
Zebrafish heart rates are regulated by ambient temperature.
Unless otherwise noted, embryos were incubated at 28.5uC (VWR
Scientific incubator, model 2030). To increase heart rates, a higher
temperature (32 or 34uC) incubator (Thermolyne, model 37900)
was used. Edema and abnormal cardiogenesis were observed when
embryos were raised at 16uC, 20uC, and 35uC.
Morpholine Oligonucleotides
Two MOs targeted against the putative translational site of klf2a
were obtained from Gene Tools LLC (59-gtaaaatcgttccactcaaagc-
cat-39-MO1; 59-agctgagatgcatggacctgtccag-39-MO2). MOs were
dissolved in 5 mM Hepes (pH 7.6) and were injected into one-cell
stage embryos (total amount of 7 or 15 ng per embryo). We found
that the two MOs induced the same range of malformations (valve
malformation: 40%, n=15 for MO1; 52%, n=36 for MO2;
edema: 33%, n=84 for MO1; 36%, n=86 for MO2). The
specificity of each MO was assessed using a standard eGFP fusion
approach where the eGFP sequence (pEGFP-N1, Clontech) was
fused by amplifying eGFP via PCR using primers containing the
target sequence of each MO and a sp6 sequence in order to
translate the PCR product (mMESSAGE mMACHINE sp6,
Ambion) (Figure S10). Control embryos were injected with a
similar amount of a standard mismatch MO provided by Gene
Tools LLC (59-agGtgaCatgcatCgacctCtcgag-39). The specificity of
this MO was addressed using the eGFP fusion approach (Figure
S11), and its effect on valve development was analyzed using
Tg(flk1:EGFP) embryos (Figure S11). Specificity of the MOs was
further assessed by analyzing the ability of klf2a mRNA
overexpression to rescue the MO-induced edema. A total of
100 pg of mRNA was coinjected with 15 ng of each MO, and
edema was scored at 32 hpf (Figure S10). MOs to gata1, gata2 and
gata1/2 were used as in [34], cx36.7 as in [15], and myh6 as in [13].
In Situ Hybridization
ISHs were performed as described in [53] using the following
probes: cmlc2, bmp4 (both provided by L. Trinh, California
Institute of Technology), notch1b (provided by M. Lardelli,
University of Adelaide), nppa (provided by T. Zhong, Vanderbilt
Medical School), and klf2a probe (obtained by PCR amplification
of the plasmid IRBOp991B0734D provided by RPDZ, Berlin).
Valve Development Assay
A random sample of experimentally manipulated embryos was
imaged at 96 hpf and scored based on the presence of valve
leaflets. A focal plane with the atrium, ventricle, and AV canal in
view was chosen to illustrate the phenotype. In cases where leaflets
were difficult to identify (,2%), the presence or absence of
transvalvular retrograde flow was used to determine abnormal or
normal valvulogenesis, respectively.
Cell Shape Assay
A random sample of experimentally manipulated Tg(flk1:EGFP)
embryos was imaged at 72 hpf, and a section plan of 10 mm was
made using the substack maker plugin with Image J. Cell shapes
were reconstructed in three dimensions using the contour surface
key in Imaris (Bitplane). A minimum of two embryos and ten cells
in each condition were reconstructed. We then calculated the ratio
of the length of the two longest sides and used a Z-test for two
proportions to perform the statistical analysis.
Real-Time RT-PCR
At 56 hpf, embryonic hearts were dissected in egg water after
MO injection or lidocaine treatment. Two to three batches of ten
hearts for each condition were pooled, and RNA was extracted
using Trizol. RT was performed using the same amount of
extracted mRNA and further tested by RT-PCR using the 96-well
plate ABI 7000 QPCR machine in a SYBR Green (Bio-Rad)
assay. The fold changes were calculated by the DCt method using
a reference gene (zebrafish TBP) and plotted as a percentage of
expression normalized to control. ANOVA tests were performed
using Instat (Graphpad Software, Inc).
Supporting Information
Figure S1 Oscillatory flow is observed in the AV canal
before valves become functional. (A–D) Confocal scans of
hearts (ventral view, anterior to the top) at four developmental
stages showing the morphology of the developing heart between
36 and 120 hpf. The endocardial tissue in the AV canal at 48 hpf
in shown by the arrow in (C). Valve leaflets appear at 84 hpf and
are mature by 120 hpf. The black box underlines the location of
blood flow analysis for each stage (A–D). Scale bar indicates
50 mm. (E–H) Transvalvular flow direction over time shows that
mature valve leaflets are necessary to prevent retrograde flow in
the heart. Anterograde flow from the atrium to ventricle is shown
in black, retrograde flow from the ventricle to the atrium in red,
and no flow between the chambers is shown in white.
Found at: doi:10.1371/journal.pbio.1000246.s001 (2.39 MB TIF)
Figure S2 klf2a expression is localized to the endothe-
lial cells of the AV canal. (A) Brightfield image of klf2a mRNA
distribution at 48 hpf using NBT-BCIP revelation. (B) Maximal
intensity projection of 15 sections obtained by confocal microscopy
(633-nm excitation wavelength) reveals the specific expression
domain of klf2a to the innermost cell layer of the heart. (C) Profile
plot of the pixel intensity measured along the bottom white line in
(B) showing increased signal in the AV canal (white arrows). (D
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and E) Drawings locating the endothelial (e) and myocardial (m)
layer on the picture. (F, I, and J) Maximal intensity projection of
ten sections obtained by confocal microscopy (633-nm excitation
wavelength) reveals that the specific expression domain of klf2a
increases and becomes brighter to the innermost cell layer of the
heart at during the valve elongation stage (60 hpf). (G) By
comparison, expression of cmlc2 labels the myocardium and not
the endothelium. (H) Same imaging procedure using an embryo
not labeled with NBT-BCIP showing no staining.
Found at: doi:10.1371/journal.pbio.1000246.s002 (6.54 MB TIF)
Figure S3 Decreased blood cells number do not affects
heart chamber patterning as well as head and trunk
vasculogenesis. (A, B, F, G, K, and L) nppa and bmp4 expression
is unaffected in gata1 (F and G) and gata2 (K and L) morphants
compared to controls (A and B) showing that heart chambers and
AV canal patterning is normal when blood cell numbers decrease.
(C–E, H–J, and M–O) GFP expression in Tg(flk1:EGFP)
delimitates the cardiovascular system as it is limited to every
endothelial cells in the embryo (C, H, and M). Details of the head
(D, I, and N) and trunk (E, J, and O) vasculature in controls (C–E),
gata1 (H–J), and gata2 (M–O) show that no obvious malformation
of the cardiovascular system is visible when blood cell number
decreases. Arrows in (D, I, and N) point to the fourth branchial
arch; arrows in (E, J, and O) point to secondary sprouts of the
trunk cardiovascular wiring. Panels (C, H, and M) are each a
composite of two original images.
Found at: doi:10.1371/journal.pbio.1000246.s003 (7.34 MB TIF)
Figure S4 Quantitative analysis of the blood flow
observed in the AV canal at 48 hpf. (A) Shear stress
estimated in the AV canal at 48 hpf. (B) Recapitulative table of
the different flow features observed in the AV canal after the
different treatments done in this paper. The energy expenditure of
blood (E) required by blood cells going through the AV canal was
calculated during the retrograde and anterograde flow portions of
the heart cycle. It directly depends on the magnitude of the wall
shear stress (WSS) and provides an estimate of the amount of WSS
received by a single cell by taking into account the period of
stimulation and the wall shear force intensity generated at each
heart beat (see Materials and Methods). (C) Normalized flow
velocity observed in gata morphants. (D) Outline summarizing the
experimental outcome of decreasing oscillatory flow by decreasing
blood viscosity (gata1 and gata2 MO). The color code for gene
expression is the same as in Figure 2.
Found at: doi:10.1371/journal.pbio.1000246.s004 (2.77 MB TIF)
Figure S5 Decreased retrograde flow via changes in
contractility affects valve morphogenesis. (A–H) Flow
pattern at 48 hpf and associated confocal sections of the valve-
forming region at 96 hpf in (A) control, (B) cx36.7 (see also Video
S6), (C) myh6 (Video S6), (D) ttna (Video S6) knock downs, and (E)
in the silent heart (sih) mutants. myh6, ttna, and sih inactivation leads
to a dramatic decrease in the RFF and valve defects, whereas
cx36.7 knock down has an almost normal RFF and valves
compared to the control. (F–H) klf2a expression in (F) control, (G)
cx36.7, and (H) myh6 morphants. Absence of klf2a expression was
observed in myh6 morphants (41%, n=36) (H), but normal
expression levels were observed in cx36.7 morphants (75%, n=50)
(G). These two populations were significantly different (a=0.1). (I)
Energy expenditure comparison between control, gata1, and myh6
morphants during the retrograde, anterograde, or both flow
direction phases. The apparition of valve dysgenesis coincides with
a low energy expenditure during phases of retrograde flow rather
than a reduction of the overall energy expenditure during phases
of anterograde and retrograde flow. (J) Proportionally decreased
RFF through treatment with cx36.7, myh6, or ttna MOs leads to an
increase in valve defects. The maximal effect is observed in no flow
(sih) or no RFF (ttna) conditions.
Found at: doi:10.1371/journal.pbio.1000246.s005 (2.26 MB TIF)
Figure S6 Strong phenotype triggered by lidocaine
treatment. (A) Control conditions (B) After treatment with
lidocaine, 17% (n=36) embryos do not have endothelial tissue
thickening. (C and D) bmp4 expression in (C) lidocaine-treated and
(D) untreated embryos. In treated embryos, the heart tube is very
immature, a situation very similar to that observed in the no-flow
conditions reported in [14]. Such embryos were not used for flow
analyses or qPCR, nor were they tested for valve morphogenesis at
later stages. White arrow points to the AV canal.
Found at: doi:10.1371/journal.pbio.1000246.s006 (5.54 MB TIF)
Figure S7 notch1b expression after lidocaine treatment.
notch1b is expressed at the AV boundary in control embryos (A and
C) and after 5 h of lidocaine treatment (100%, n=47; (B)) but
disappears after 15 h of lidocaine treatment (61%, n=36; (D)).
Anterior is to the top.
Found at: doi:10.1371/journal.pbio.1000246.s007 (1.44 MB TIF)
Figure S8 Expression of notch1b, bmp4, and cmlc2 in
control ([A, C, and E], respectively) and klf2a MO-
treated ([B, D, and F], respectively) embryos. A strong
phenotype after klf2a MO treatment is visible in a minority
fraction of embryos treated with klf2a MO, which display
immature heart growth (13%, n=20). In these strongly affected
embryos, the heart tube morphology is similar to that observed in
conditions were blood flow is suppressed (see [7]); they were not
used for flow analysis, qPCR, or for scoring valve morphogenesis
at later stages.
Found at: doi:10.1371/journal.pbio.1000246.s008 (1.60 MB TIF)
Figure S9 Expression of three marker genes at 36 hpf in
the heart of normal and klf2a morphants. (A and B) cmlc2
expression is essentially normal in the klf2a morphants, showing
that chamber specification occurs independently of klf2a. (C and
D) bmp4 mRNA distribution at 36 hpf showing that expression is
normal in the MO-treated embryo in the AV node region at that
stage. (E and F) notch1b expression decreases in the AV boundary
of the klf2a morphants at 36 hpf (n=24, 63%; compare expression
at tip of arrows). Arrows point to the AV boundary in all panels.
Found at: doi:10.1371/journal.pbio.1000246.s009 (2.53 MB TIF)
Figure S10 Validation of the MO strategy. (A–L) MOs
against klf2a block the translation of eGFP fusion proteins carrying
their target sequences. (M–X) Control MO (a mismatch of MO2)
do inhibit the translation of eGFP fusion proteins carrying its
target sequence (M–R), whereas MOs directed against klf2a cannot
block the translation of the target sequence of the mismatch MO
(S–X), validating the specificity of each MO.
Found at: doi:10.1371/journal.pbio.1000246.s010 (5.16 MB TIF)
Figure S11 (A–E) Injection of klf2a mismatch morpho-
lino does not affect valve invagination and cell shape. (F)
Overexpression of klf2a mRNA rescues klf2a MO-mediated
phenotype. (A–B’) Comparison of the valve phenotype between
the different treatment affecting valvulogenesis using Tg (flk1:egfp)
at 72 hpf. GFP is expressed in the endothelial cell layer and
highlights the developing valves. (A, B, and B’) control embryo, (C,
D, and D’) klf2a mismatch morphant. (B’ and D’) Schematic
representation of the panels (B and D) outlining the endothelial
cells within valve-forming region (yellow) and the heart lumen
(white). Mismatch MO injection leads to a normal ingression of
the endothelial cells and cuboidal cell rearrangement showing that
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leaflet invagination occurs properly and that there is no
nonspecific effects due to MO injection. (F) Percentage of rescue
obtained after overexpression of klf2a mRNA concomitantly with
klf2a MO (n=115 for MO1, n=49 for MO2) compared with klf2a
MO injected embryos (n=84 for MO1 and n=88 for MO2). A,
atrium; V, ventricle.
Found at: doi:10.1371/journal.pbio.1000246.s011 (1.70 MB TIF)
Video S1 Transvalvular flow changes dramatically
during cardiac morphogenesis. Heartbeats in BODIPY-
ceramide-stained embryos from four developmental stages (36, 72,
84 and 120 hpf) are shown. At each stage, the age, period length,
and transvalvular flow direction are shown. Valve leaflets begin to
develop by 84 hpf and are mature by 120 hpf. Transvalvular
retrograde flow exists until mature valve leaflets develop.
Found at: doi:10.1371/journal.pbio.1000246.s012 (5.58 MB
MOV)
Video S2 Three dimensional reconstruction of klf2a
expression in the AV canal endothelium.
Found at: doi:10.1371/journal.pbio.1000246.s013 (2.37 MB
MOV)
Video S3 Transvalvular flow changes in the AV canal
and atrium at 36 hpf, 48 hpf, and 56 hpf in wild-type
embryos (which also serve as controls [CTL]).
Found at: doi:10.1371/journal.pbio.1000246.s014 (8.86 MB AVI)
Video S4 Transvalvular flow changes in the A–V canal
in gata1 morphants, gata2 morphants and gata1/2
morphants at 48 hpf. The RFF is increased in gata1 and
gata1/2 compared to controls (see Video S3), whereas the RFF in
gata2 morphants is decreased compared to controls, gata1, and
gata1/2 morphants.
Found at: doi:10.1371/journal.pbio.1000246.s015 (8.34 MB
MOV)
Video S5 Hematocrit is severely reduced in gata2
morphants at 48 hpf. Blood cells traveling in an eye capillary
in control (top panel in the video) and gata2 morphant (bottom
panel of the video).
Found at: doi:10.1371/journal.pbio.1000246.s016 (0.60 MB
MOV)
Video S6 Transvalvular flow changes in the AV canal in
cx36.7, ttna, and myh6 morphants at 48 hpf.
Found at: doi:10.1371/journal.pbio.1000246.s017 (9.25 MB
MOV)
Video S7 Transvalvular flow changes in the AV canal of
control embryos at 3 Hz, 2.4 Hz, 1.5 Hz, and 1.2 Hz.
Wild-type hearts at 48 hpf display normal RFF when incubated at
normal temperatures but display reduced RFF when incubated at
elevated temperatures (which artificially increases the heart rate)
and when incubated at low temperatures (which artificially
decreases the heart rate).
Found at: doi:10.1371/journal.pbio.1000246.s018 (9.70 MB
MOV)
Video S8 Reduced oscillatory flow leads to heart valve
dysgenesis. Wild-type hearts at 96 hpf have functional valve
leaflets that prevent retrograde flow across the AV valve. Fish
exposed to reduced oscillatory flow through lidocaine exposure
experience valve dysgenesis. Retrograde flow results from the
absence of valve leaflets. Fish exposed to lidocaine and incubated
at elevated temperatures, restoring the natural heart rate, do not
experience valve dysgenesis.
Found at: doi:10.1371/journal.pbio.1000246.s019 (8.40 MB
MOV)
Video S9 Three-dimensional cell shape in the AV canal
of transgenic Tg(flk1:EGFP) embryos at 72 hpf in a
control embryo, in gata1, gata2, and klf2a morphants,
and in a lidocaine-treated embryo. GFP is expressed in the
endothelial cell layer (in white) and the yellow shape highlights the
cell shape of one cell in the developing valves.
Found at: doi:10.1371/journal.pbio.1000246.s020 (3.56 MB
MOV)
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